[IMRX] YoY Quarter Result on 30-Sep-2024 [#Q3]

Stock
[IMRX] Immuneering Corporation
Announcement Date
13-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- -3.67%
YoY- -15.90%
Quarter Report
IMRX's Result
IMRX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 CAGR
Revenue 0 0 38 482 683 -
PBT -14,597 -12,595 -12,844 -8,534 -4,399 34.93%
Tax 0 -13,912,372 -344 -17 -0 -
NP -14,597 -12,595 -12,501 -8,534 -4,399 34.93%
Tax Rate - - - - - -
Total Cost 14,597 12,595 12,539 9,016 5,082 30.16%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 CAGR
NP Margin 0.00 0.00 -32,570.38 -1,770.08 -644.49 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 CAGR
EPS -0.49 -0.43 -0.47 -0.47 -0.33 10.38%
EPS Diluted -0.49 -0.43 -0.47 -0.47 -0.33 10.38%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.